NCT01298687 - Divided Dose of TRAVATAN® | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions

Open-angle GlaucomaOcular Hypertension

Interventions

DRUG

Travoprost Ophthalmic Solution, 0.00013%

Cumulative daily dose is below the travoprost ophthalmic solution, 0.004% once daily dose

DRUG

Travoprost Ophthalmic Solution, 0.00033%

Cumulative daily dose equals the travoprost ophthalmic solution, 0.004% once daily dose

DRUG

Travoprost Ophthalmic Solution, 0.001%

Cumulative daily dose is above the travoprost ophthalmic solution, 0.004% once daily dose

DRUG

Travoprost Ophthalmic Solution, 0.00267%

Cumulative daily dose is above the travoprost ophthalmic solution, 0.004% once daily dose

DRUG

Travoprost Ophthalmic Solution, 0.004%

DRUG

Travoprost Vehicle

Inactive ingredients used as an active comparator